-
1دورية أكاديمية
المؤلفون: Janice M. Mehnert, Andrea Varga, Marcia S. Brose, Rahul R. Aggarwal, Chia-Chi Lin, Amy Prawira, Filippo de Braud, Kenji Tamura, Toshihiko Doi, Sarina A. Piha-Paul, Jill Gilbert, Sanatan Saraf, Pradeep Thanigaimani, Jonathan D. Cheng, Bhumsuk Keam
المصدر: BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
مصطلحات موضوعية: Thyroid cancer, Immunotherapy, Pembrolizumab, Anti–PD-1, PD-1, PD-L1, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://link.springer.com/article/10.1186/s12885-019-5380-3Test; https://doaj.org/toc/1471-2407Test
-
2دورية أكاديمية
المؤلفون: Bert H O'Neil, John M Wallmark, David Lorente, Elena Elez, Judith Raimbourg, Carlos Gomez-Roca, Samuel Ejadi, Sarina A Piha-Paul, Mark N Stein, Albiruni R Abdul Razak, Katia Dotti, Armando Santoro, Roger B Cohen, Marlena Gould, Sanatan Saraf, Karen Stein, Sae-Won Han
المصدر: PLoS ONE, Vol 12, Iss 12, p e0189848 (2017)
وصف الملف: electronic resource
العلاقة: http://europepmc.org/articles/PMC5746232?pdf=renderTest; https://doaj.org/toc/1932-6203Test
-
3دورية أكاديمية
المؤلفون: Andrew E Hendifar, Douglas A Levine, Ronnie Shapira-Frommer, Sanatan Saraf, Michele Maio, Timothy A Yap, Mallika Dhawan, Taofeek K Owonikoko, Miguel Quintela-Fandino, Ping Qiu, Fan Jin, Alexander Gozman
المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
العلاقة: https://doaj.org/toc/2051-1426Test; https://doaj.org/article/eed07383004a43a6bb189df2d00a2ac3Test
الإتاحة: https://doi.org/10.1136/jitc-2020-SITC2020.0318Test
https://doaj.org/article/eed07383004a43a6bb189df2d00a2ac3Test -
4
المؤلفون: Antoinette R. Tan, Vassiliki Karantza, Dina Pietrangelo, Sanatan Saraf, Sherene Loi, Roberto Salgado, Andrea Varga, Emilie M.J. van Brummelen, Christophe Le Tourneau, Jasgit Sachdev, Philippe L. Bedard, Sarina A. Piha-Paul, Patrick A. Ott, Seock-Ah Im, Jean-Pierre Delord, Hope S. Rugo
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d52b661d64664fa409d416dc233b1cfTest
https://doi.org/10.1158/1078-0432.22469805Test -
5
المؤلفون: Antoinette R. Tan, Vassiliki Karantza, Dina Pietrangelo, Sanatan Saraf, Sherene Loi, Roberto Salgado, Andrea Varga, Emilie M.J. van Brummelen, Christophe Le Tourneau, Jasgit Sachdev, Philippe L. Bedard, Sarina A. Piha-Paul, Patrick A. Ott, Seock-Ah Im, Jean-Pierre Delord, Hope S. Rugo
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7000ba3fff57d7f46c656ca88a5dc07aTest
https://doi.org/10.1158/1078-0432.c.6527355.v1Test -
6
المؤلفون: Amita Patnaik, Matthew A. Gubens, Shirish M. Gadgeel, James P. Stevenson, Bilal Piperdi, Ryan D. Gentzler, Mark M. Awad, Shadia I. Jalal, Mehmet Altan, Lecia V. Sequist, Amit Panwalkar, Bin Zhao, James Chih-Hsin Yang, Sanatan Saraf, Hossein Borghaei, Steven Francis Powell, Renato G. Martins, Corey J. Langer
المصدر: Journal of Thoracic Oncology. 16:162-168
مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, Randomization, medicine.medical_treatment, Pemetrexed, Pembrolizumab, Antibodies, Monoclonal, Humanized, Carboplatin, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Chemotherapy, business.industry, Hazard ratio, Confidence interval, 030104 developmental biology, chemistry, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cfcf24c97ea524d6ee05ebef4f83c41Test
https://doi.org/10.1016/j.jtho.2020.09.015Test -
7
المؤلفون: Sanatan Saraf, Hossein Borghaei, Corey J. Langer, Shirish M. Gadgeel, Matthew A. Gubens, Shadia I. Jalal, Harry Raftopoulos, Amita Patnaik, Steven Francis Powell, James P. Stevenson, Leena Gandhi, Lecia V. Sequist, Joseph Fiore, Liza C. Villaruz
المصدر: Lung Cancer. 130:59-66
مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, medicine.medical_specialty, Chemotherapy, Combination therapy, business.industry, medicine.medical_treatment, Ipilimumab, Pembrolizumab, medicine.disease, Targeted therapy, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Cohort, medicine, Lung cancer, Adverse effect, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::85987bb26bcd844f0485a846070099b4Test
https://doi.org/10.1016/j.lungcan.2018.12.015Test -
8
المؤلفون: Sanatan Saraf, Vassiliki A. Papadimitrakopoulou, Chien Liang Wu, Wu Chou Su, Amita Patnaik, Shirish M. Gadgeel, Lecia V. Sequist, Harry Raftopoulos, Joseph Fiore, James Chih-Hsin Yang
المصدر: Journal of Thoracic Oncology. 14:553-559
مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, medicine.medical_treatment, Pembrolizumab, 03 medical and health sciences, 0302 clinical medicine, Gefitinib, Internal medicine, medicine, Adverse effect, neoplasms, business.industry, Immunotherapy, Rash, respiratory tract diseases, Discontinuation, 030104 developmental biology, 030220 oncology & carcinogenesis, Cohort, Erlotinib, medicine.symptom, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::d590dac7eac4450bcfaf5f74f9499355Test
https://doi.org/10.1016/j.jtho.2018.11.028Test -
9
المؤلفون: Chia-Chi Lin, Rahul Aggarwal, Sarina Anne Piha-Paul, Janice M. Mehnert, Kenji Tamura, Amy Prawira, Toshihiko Doi, Andrea Varga, Sanatan Saraf, Jill Gilbert, Pradeep Thanigaimani, Jonathan D. Cheng, Filippo de Braud, Bhumsuk Keam, Marcia S. Brose
المصدر: BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Cancerمصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, medicine.medical_treatment, Pembrolizumab, B7-H1 Antigen, 0302 clinical medicine, Antineoplastic Agents, Immunological, Surgical oncology, Adenocarcinoma, Follicular, PD-1, Clinical endpoint, Thyroid cancer, Fatigue, Middle Aged, Colitis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Progression-Free Survival, Treatment Outcome, Response Evaluation Criteria in Solid Tumors, Thyroid Cancer, Papillary, 030220 oncology & carcinogenesis, Anti–PD-1, Female, Immunotherapy, Research Article, Adult, Diarrhea, PD-L1, medicine.medical_specialty, Antibodies, Monoclonal, Humanized, Proof of Concept Study, lcsh:RC254-282, 03 medical and health sciences, Young Adult, Internal medicine, Genetics, medicine, Humans, Thyroid Neoplasms, Follicular thyroid cancer, Adverse effect, Aged, business.industry, medicine.disease, 030104 developmental biology, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac7760199bec8b1864e8087c1ae9c73aTest
http://link.springer.com/article/10.1186/s12885-019-5380-3Test -
10
المؤلفون: Vassiliki A. Papadimitrakopoulou, Ryan D. Gentzler, Lecia V. Sequist, Renato G. Martins, James P. Stevenson, Shirish M. Gadgeel, Matthew A. Gubens, Mark M. Awad, Leena Gandhi, Corey J. Langer, Amita Patnaik, Joseph Fiore, Hossein Borghaei, Steven Francis Powell, Amit Panwalkar, Shadia I. Jalal, James Chih-Hsin Yang, Sanatan Saraf, Steven M. Keller
المصدر: Journal of Thoracic Oncology. 14:124-129
مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Combination therapy, medicine.medical_treatment, Pembrolizumab, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, medicine, Lung cancer, Chemotherapy, business.industry, Hazard ratio, medicine.disease, Carboplatin, Confidence interval, 030104 developmental biology, Pemetrexed, chemistry, 030220 oncology & carcinogenesis, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4eba60487607901356e9cd5251e5ef87Test
https://doi.org/10.1016/j.jtho.2018.08.004Test